Literature DB >> 33976506

Dyslipidemia, Not Inflammatory Markers or Adipokines, Contributes Significantly to a Higher SYNTAX Score in Stable Coronary Artery Disease (from the Taichung CAD Study).

Tzu-Hsiang Lin1, Wen-Lieng Lee1,2, Wen-Jane Lee3,4, Wayne Huey-Herng Sheu2,5,6,7, Ying-Chieh Liao1,2,8, Kae-Woei Liang1,2.   

Abstract

BACKGROUND: The SYNTAX score is an index of coronary severity used to determine the revascularization strategy of a patient. Our previous study confirmed that the SYNTAX score is helpful in predicting major adverse cardiac events in patients with stable coronary artery disease (CAD). However, few studies have comprehensively investigated the predictors for SYNTAX scores in patients with stable CAD, including conventional risk factors, lipid parameters, inflammatory markers and adipokines.
METHODS: The coronary severities of 181 revascularization-naïve CAD patients who had received coronary angiograms were coded using SYNTAX scores. Conventional risk factors, inflammatory markers, and adipokines were investigated in order to determine the independent predictors for SYNTAX severity in the patients with stable CAD.
RESULTS: The SYNTAX severity score was divided according to the generally accepted criterion (low: ≤ 22, intermediate-high: ≥ 23). In univariate comparisons, the intermediate-high SYNTAX group had a significantly higher low-density lipoprotein cholesterol (LDL-C) level compared to the low SYNTAX score group (p = 0.046). In binary logistic regression, LDL-C, total cholesterol, ratio of total cholesterol/high-density lipoprotein cholesterol (HDL-C) and pre- admission statin use were significant predictors for a higher SYNTAX severity score in the patients with stable CAD. In contrast, circulating adipokines, high-sensitivity C-reactive protein and HDL-C alone were not.
CONCLUSIONS: In revascularization-naïve CAD patients, dyslipidemia, including elevated LDL-C, total cholesterol, total cholesterol/HDL-C ratio and pre-index admission statin use, were associated with an intermediate-high SYNTAX severity score.

Entities:  

Keywords:  Adiponectin; Cholesterol; Coronary artery disease; High-sensitivity C-reactive protein; Low-density lipoprotein cholesterol; SYNTAX score

Year:  2021        PMID: 33976506      PMCID: PMC8107712          DOI: 10.6515/ACS.202105_37(3).20201116B

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  33 in total

1.  Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.

Authors:  David Chieng; Jing Pang; Katrina L Ellis; Graham S Hillis; Gerald F Watts; Carl J Schultz
Journal:  J Clin Lipidol       Date:  2018-04-03       Impact factor: 4.766

2.  An assessment of risk factors for the complexity of coronary artery disease using the SYNTAX score.

Authors:  Tetsuya Tanaka; Shinji Seto; Kazuto Yamamoto; Morihiko Kondo; Toshiyuki Otomo
Journal:  Cardiovasc Interv Ther       Date:  2012-08-09

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  A more meaningful scoring system for determining the severity of coronary heart disease.

Authors:  G G Gensini
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

5.  Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention.

Authors:  Yue Liu; Si-da Jia; Yi Yao; Xiao-Fang Tang; Na Xu; Lin Jiang; Zhan Gao; Jue Chen; Yue-Jin Yang; Run-Lin Gao; Bo Xu; Jin-Qing Yuan
Journal:  J Cardiol       Date:  2019-08-13       Impact factor: 3.159

6.  High Sensitive CRP Level Is Associated With Intermediate and High Syntax Score in Patients With Acute Coronary Syndrome.

Authors:  Muhammed Karadeniz; Mustafa Duran; Ahmet Akyel; Mikail Yarlıoğlueş; Adil Hakan Öcek; İbrahim Etem Çelik; Alparslan Kılıç; Ahmet Arif Yalcin; Gökhan Ergün; Sani Namık Murat
Journal:  Int Heart J       Date:  2015-06-26       Impact factor: 1.862

7.  Plasma adiponectin levels and risk of myocardial infarction in men.

Authors:  Tobias Pischon; Cynthia J Girman; Gokhan S Hotamisligil; Nader Rifai; Frank B Hu; Eric B Rimm
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

8.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

9.  Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris.

Authors:  Kae-Woei Liang; Wayne Huey-Herng Sheu; Wen-Lieng Lee; Tsun-Jui Liu; Chih-Tai Ting; Yu-Cheng Hsieh; Kuo-Yang Wang; Ying-Tsung Chen; Wen-Jane Lee
Journal:  Int J Cardiol       Date:  2007-07-24       Impact factor: 4.164

10.  Prognostic value of a coronary artery jeopardy score.

Authors:  R M Califf; H R Phillips; M C Hindman; D B Mark; K L Lee; V S Behar; R A Johnson; D B Pryor; R A Rosati; G S Wagner
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

View more
  1 in total

1.  Association between Circulating Omentin-1 Levels and Aortic Valve Sclerosis.

Authors:  Mustafa Dogdus; Ferhat Dindas; Yusuf Cekici; Arafat Yildirim; Mehmet Kucukosmanoglu; Nermin Yildiz Koyunsever; Ozge Ozcan Abacioglu; Salih Kilic
Journal:  Acta Cardiol Sin       Date:  2022-09       Impact factor: 1.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.